Structure Therapeutics Inc. (GPCR) Free cash flow 2022–2025
Structure Therapeutics Inc. (GPCR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$225.8MFY2025 · since FY2022: -$46.3M → -$225.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$225.8M | -91.5% |
| FY2024 | -$117.9M | -44.4% |
| FY2023 | -$81.7M | -76.5% |
| FY2022 | -$46.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice